Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 234

1.

Cervical spinal cord atrophy: An early marker of progressive MS onset.

Zeydan B, Gu X, Atkinson EJ, Keegan BM, Weinshenker BG, Tillema JM, Pelletier D, Azevedo CJ, Lebrun-Frenay C, Siva A, Okuda DT, Kantarci K, Kantarci OH.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 22;5(2):e435. doi: 10.1212/NXI.0000000000000435. eCollection 2018 Mar.

2.

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA.

Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Review.

PMID:
29275977
3.

Optic Disc Edema in Glial Fibrillary Acidic Protein Autoantibody-Positive Meningoencephalitis.

Chen JJ, Aksamit AJ, McKeon A, Pittock SJ, Weinshenker BG, Leavitt JA, Morris PP, Flanagan EP.

J Neuroophthalmol. 2017 Nov 21. doi: 10.1097/WNO.0000000000000593. [Epub ahead of print]

PMID:
29210929
4.

Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management.

Shosha E, Pittock SJ, Flanagan E, Weinshenker BG.

Mult Scler. 2017 Dec;23(14):1808-1817. doi: 10.1177/1352458517740215.

PMID:
29154728
5.

A population-based prospective study of optic neuritis.

Soelberg K, Jarius S, Skejoe H, Engberg H, Mehlsen JJ, Nilsson AC, Madsen JS, Reindl M, Wildemann B, Grauslund J, Kyvik KO, Smith TJ, Lillevang ST, Paul F, Weinshenker BG, Asgari N.

Mult Scler. 2017 Dec;23(14):1893-1901. doi: 10.1177/1352458517734070. Epub 2017 Oct 5.

PMID:
28980518
6.

Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - NO.

Tobin WO, Weinshenker BG.

Mult Scler. 2017 Aug;23(9):1190-1192. doi: 10.1177/1352458517702556. Epub 2017 Jul 4. No abstract available.

PMID:
28673112
7.

Elsberg syndrome: A rarely recognized cause of cauda equina syndrome and lower thoracic myelitis.

Savoldi F, Kaufmann TJ, Flanagan EP, Toledano M, Weinshenker BG.

Neurol Neuroimmunol Neuroinflamm. 2017 May 11;4(4):e355. doi: 10.1212/NXI.0000000000000355. eCollection 2017 Jul.

8.

Author response: The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Solomon AJ, Weinshenker BG.

Neurology. 2017 May 23;88(21):2067-2068. doi: 10.1212/WNL.0000000000003973. No abstract available.

PMID:
28533349
9.

Baló concentric sclerosis evolving from apparent tumefactive demyelination.

Hardy TA, Corboy JR, Weinshenker BG.

Neurology. 2017 May 30;88(22):2150-2152. doi: 10.1212/WNL.0000000000003990. Epub 2017 May 3. No abstract available. Erratum in: Neurology. 2017 Jul 25;89(4):411.

PMID:
28468846
10.

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.

Asgari N, Flanagan EP, Fujihara K, Kim HJ, Skejoe HP, Wuerfel J, Kuroda H, Kim SH, Maillart E, Marignier R, Pittock SJ, Paul F, Weinshenker BG.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 21;4(4):e343. doi: 10.1212/NXI.0000000000000343. eCollection 2017 Jul.

11.

Neuromyelitis Spectrum Disorders.

Weinshenker BG, Wingerchuk DM.

Mayo Clin Proc. 2017 Apr;92(4):663-679. doi: 10.1016/j.mayocp.2016.12.014. Review.

PMID:
28385199
12.

Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study.

Asgari N, Jarius S, Laustrup H, Skejoe HP, Lillevang ST, Weinshenker BG, Voss A.

Mult Scler. 2017 Mar 1:1352458517699791. doi: 10.1177/1352458517699791. [Epub ahead of print]

PMID:
28326889
13.

Myelitis in neuromyelitis optica spectrum disorder: The long and the short of it.

Flanagan EP, Weinshenker BG.

Mult Scler. 2017 Mar;23(3):360-361. doi: 10.1177/1352458517692888. No abstract available.

PMID:
28260418
14.

Variation in MS outcome: Race, place, or both?

Weinshenker BG, Lucas RM.

Neurology. 2017 Mar 28;88(13):1214-1215. doi: 10.1212/WNL.0000000000003776. Epub 2017 Feb 24. No abstract available.

PMID:
28235813
15.

Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.

Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A.

Ann Neurol. 2017 Feb;81(2):298-309. doi: 10.1002/ana.24881.

PMID:
28120349
16.

Neuromyelitis optica spectrum disorder diagnostic criteria: Sensitivity and specificity are both important.

Wingerchuk DM, Weinshenker BG.

Mult Scler. 2017 Feb;23(2):182-184. doi: 10.1177/1352458516688352. Epub 2017 Jan 12. No abstract available.

PMID:
28080211
17.

Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders.

Zalewski NL, Morris PP, Weinshenker BG, Lucchinetti CF, Guo Y, Pittock SJ, Krecke KN, Kaufmann TJ, Wingerchuk DM, Kumar N, Flanagan EP.

J Neurol Neurosurg Psychiatry. 2017 Mar;88(3):218-225. doi: 10.1136/jnnp-2016-314738. Epub 2016 Dec 2.

PMID:
27913626
18.

Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.

Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP.

Neurology. 2016 Oct 18;87(16):1713-1719. Epub 2016 Sep 16.

19.

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG.

Neurology. 2016 Sep 27;87(13):1393-9. doi: 10.1212/WNL.0000000000003152. Epub 2016 Aug 31.

20.

Disease modifying therapies for relapsing multiple sclerosis.

Wingerchuk DM, Weinshenker BG.

BMJ. 2016 Aug 22;354:i3518. doi: 10.1136/bmj.i3518. Review.

PMID:
27549763
21.

Central canal enhancement and the trident sign in spinal cord sarcoidosis.

Zalewski NL, Krecke KN, Weinshenker BG, Aksamit AJ, Conway BL, McKeon A, Flanagan EP.

Neurology. 2016 Aug 16;87(7):743-4. doi: 10.1212/WNL.0000000000002992. No abstract available.

PMID:
27527540
22.

Does early (treatment in) BENEFIT lead to late MS benefit?

Healy BC, Weinshenker BG.

Neurology. 2016 Sep 6;87(10):970-1. doi: 10.1212/WNL.0000000000003070. Epub 2016 Aug 10. No abstract available.

PMID:
27511185
23.

Atypical inflammatory demyelinating syndromes of the CNS.

Hardy TA, Reddel SW, Barnett MH, Palace J, Lucchinetti CF, Weinshenker BG.

Lancet Neurol. 2016 Aug;15(9):967-981. doi: 10.1016/S1474-4422(16)30043-6. Review.

PMID:
27478954
24.

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.

Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Soldan MM, Luckey DH, Marietta EV, Jeraldo PR, Chen X, Weinshenker BG, Rodriguez M, Kantarci OH, Nelson H, Murray JA, Mangalam AK.

Sci Rep. 2016 Jun 27;6:28484. doi: 10.1038/srep28484.

25.

Posterior reversible encephalopathy syndrome is not associated with mutations in aquaporin-4.

Matiello M, Muralidharan R, Sun D, Rabinstein AA, Weinshenker BG.

Neurol Genet. 2015 Jul 16;1(2):e19. doi: 10.1212/NXG.0000000000000013. eCollection 2015 Aug.

26.

Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.

Flanagan EP, Cabre P, Weinshenker BG, St Sauver J, Jacobson DJ, Majed M, Lennon VA, Lucchinetti CF, McKeon A, Matiello M, Kale N, Wingerchuk DM, Mandrekar J, Sagen JA, Fryer JP, Borders Robinson A, Pittock SJ.

Ann Neurol. 2016 Feb 17. doi: 10.1002/ana.24617. [Epub ahead of print]

27.

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Tan CT, Mao Z, Qiu W, Hu X, Wingerchuk DM, Weinshenker BG.

Neurology. 2016 Feb 2;86(5):491-2. doi: 10.1212/WNL.0000000000002366. No abstract available.

PMID:
26833940
28.

Discriminating long myelitis of neuromyelitis optica from sarcoidosis.

Flanagan EP, Kaufmann TJ, Krecke KN, Aksamit AJ, Pittock SJ, Keegan BM, Giannini C, Weinshenker BG.

Ann Neurol. 2016 Mar;79(3):437-47. doi: 10.1002/ana.24582. Epub 2016 Feb 12.

PMID:
26677112
29.

What Is the Optimal Sequence of Rescue Treatments for Attacks of Neuromyelitis Optica Spectrum Disorder?

Weinshenker BG.

Ann Neurol. 2016 Feb;79(2):204-5. doi: 10.1002/ana.24557. Epub 2016 Jan 14. No abstract available.

PMID:
26575334
30.

Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?

Weinshenker BG.

Mult Scler. 2015 Nov;21(13):1746-7. doi: 10.1177/1352458515603801. Epub 2015 Sep 11.

PMID:
26362899
31.

Stopping immunomodulatory medications in MS: Frequency, reasons and consequences.

Tobin WO, Weinshenker BG.

Mult Scler Relat Disord. 2015 Sep;4(5):437-443. doi: 10.1016/j.msard.2015.07.004. Epub 2015 Jul 8. Review. Erratum in: Mult Scler Relat Disord. 2016 Jan;5():105.

PMID:
26346792
32.

Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.

Novotna M, Paz Soldán MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, Kantarci OH.

Neurology. 2015 Aug 25;85(8):722-9. doi: 10.1212/WNL.0000000000001856. Epub 2015 Jul 24. Erratum in: Neurology. 2015 Oct 13;85(15):1355.

33.

Teaching NeuroImages: Primary Sjögren syndrome presenting as isolated lesion of medulla oblongata.

Tobin WO, Pittock SJ, Weinshenker BG.

Neurology. 2015 Jul 14;85(2):204-5. doi: 10.1212/01.wnl.0000469900.24335.36. No abstract available.

PMID:
26170403
34.

Corticosteroid-Induced Paraplegia—A Diagnostic Clue for Spinal Dural Arterial Venous Fistula.

O'Keeffe DT, Mikhail MA, Lanzino G, Kallmes DF, Weinshenker BG.

JAMA Neurol. 2015 Jul;72(7):833-4. doi: 10.1001/jamaneurol.2015.0757. No abstract available.

PMID:
26167899
35.

Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy.

Flanagan EP, Weinshenker BG, Krecke KN, Pittock SJ.

Neurol Clin Pract. 2015 Apr;5(2):175-177. No abstract available.

36.

A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis.

Toledano M, Weinshenker BG, Solomon AJ.

Curr Neurol Neurosci Rep. 2015 Aug;15(8):57. doi: 10.1007/s11910-015-0576-7. Review.

PMID:
26112766
37.

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG; International Panel for NMO Diagnosis.

Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.

38.

Placebo Studies should not be Undertaken in Neuromyelitis Optica: Commentary.

Weinshenker BG.

Mult Scler. 2015 May;21(6):693-4. doi: 10.1177/1352458515580402. Epub 2015 Apr 28. No abstract available.

PMID:
25921043
39.

Challenges and opportunities in designing clinical trials for neuromyelitis optica.

Weinshenker BG, Barron G, Behne JM, Bennett JL, Chin PS, Cree BA, de Seze J, Flor A, Fujihara K, Greenberg B, Higashi S, Holt W, Khan O, Knappertz V, Levy M, Melia AT, Palace J, Smith TJ, Sormani MP, Van Herle K, VanMeter S, Villoslada P, Walton MK, Wasiewski W, Wingerchuk DM, Yeaman MR; Guthy-Jackson Charitable Foundation International Clinical Consortium.

Neurology. 2015 Apr 28;84(17):1805-15. doi: 10.1212/WNL.0000000000001520. Epub 2015 Apr 3. Review.

40.

Moving targets for hematopoietic stem cell transplantation for multiple sclerosis.

Paz Soldán MM, Weinshenker BG.

JAMA Neurol. 2015 Feb;72(2):147-9. doi: 10.1001/jamaneurol.2014.3831. No abstract available.

PMID:
25546257
41.

Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.

Popescu BF, Guo Y, Jentoft ME, Parisi JE, Lennon VA, Pittock SJ, Weinshenker BG, Wingerchuk DM, Giannini C, Metz I, Brück W, Shuster EA, Carter J, Boyd CD, Clardy SL, Cohen BA, Lucchinetti CF.

Neurology. 2015 Jan 13;84(2):148-58. doi: 10.1212/WNL.0000000000001126. Epub 2014 Dec 10.

42.

Relapses and disability accumulation in progressive multiple sclerosis.

Paz Soldán MM, Novotna M, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Weinshenker BG, Rodriguez M, Kantarci OH.

Neurology. 2015 Jan 6;84(1):81-8. doi: 10.1212/WNL.0000000000001094. Epub 2014 Nov 14.

43.

Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.

Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, Wingerchuk DM, Shuster EA, Jiao Y, Horta ES, Pittock SJ.

JAMA Neurol. 2015 Jan;72(1):81-7. doi: 10.1001/jamaneurol.2014.2137.

44.

AQP4 autoantibody assay performance in clinical laboratory service.

Fryer JP, Lennon VA, Pittock SJ, Jenkins SM, Fallier-Becker P, Clardy SL, Horta E, Jedynak EA, Lucchinetti CF, Shuster EA, Weinshenker BG, Wingerchuk DM, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2014 May 22;1(1):e11. doi: 10.1212/NXI.0000000000000011. eCollection 2014 Jun.

45.

Evaluation of aquaporin-4 antibody assays.

Waters PJ, Pittock SJ, Bennett JL, Jarius S, Weinshenker BG, Wingerchuk DM.

Clin Exp Neuroimmunol. 2014 Oct;5(3):290-303. Epub 2014 Apr 22.

46.

Pregnancy outcomes in a woman with neuromyelitis optica.

Asgari N, Henriksen TB, Petersen T, Lillevang ST, Weinshenker BG.

Neurology. 2014 Oct 21;83(17):1576-7. doi: 10.1212/WNL.0000000000000911. Epub 2014 Sep 19. No abstract available.

PMID:
25239834
47.

Neuromyelitis optica spectrum disorders.

Flanagan EP, Weinshenker BG.

Curr Neurol Neurosci Rep. 2014 Sep;14(9):483. doi: 10.1007/s11910-014-0483-3. Review.

PMID:
25027264
48.

Active and progressive: a new duality of MS classification.

Cross AH, Wingerchuk DM, Weinshenker BG.

Neurology. 2014 Jul 15;83(3):206-7. doi: 10.1212/WNL.0000000000000601. Epub 2014 Jun 13. No abstract available.

PMID:
24928117
49.

Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient.

Kravljanac R, Martinović V, Dujmović I, Djurić M, Kuzmanović M, Weinshenker BG, Drulović J.

Mult Scler. 2014 Sep;20(10):1404-6. doi: 10.1177/1352458514536254. Epub 2014 May 27.

PMID:
24866202
50.

Specific pattern of gadolinium enhancement in spondylotic myelopathy.

Flanagan EP, Krecke KN, Marsh RW, Giannini C, Keegan BM, Weinshenker BG.

Ann Neurol. 2014 Jul;76(1):54-65. doi: 10.1002/ana.24184. Epub 2014 Jun 14.

PMID:
24838831

Supplemental Content

Loading ...
Support Center